Opinion
Guidelines on GLP1RAs and continuous glucose monitors are among biggest news in diabetes
- Author:
- Irl B. Hirsch, MD
Publish date: August 22, 2022
Some GLP1RAs have shown impressive weight reduction properties and cardiovascular benefits, says an endocrinologist.
Article
Type 2 diabetes: The role of basal insulin therapy
- Author:
- Derek Leroith, MD, PhD, FACP
- Claresa S. Levetan, MD, FACE
- Irl B. Hirsch, MD
- Matthew C. Riddle, MD